Immunoprecise Antibodies Ltd. (IPA) has released an update.
Immunoprecise Antibodies Ltd. (IPA), a leader in AI-driven biotherapeutic research, is set to discuss its third-quarter financial results and recent business achievements in a live webcast on March 14, 2024. Investors and interested parties can access the conference call and replay through the company’s investor relations website. The earnings report will be made public prior to the 10:30 AM Eastern Time call.
For further insights into IPA stock, check out TipRanks’ Stock Analysis page.
